Goldman is a neurologist in charlottesville, virginia and is affiliated with one hospital. Factors for lower walking speed in persons with multiple sclerosis. The multiple sclerosis walking scale12 msws12 is a 12item selfreport. An equation for mapping the msws 12 to the eq5d was previously developed and validated using a north american research committee on ms narcoms registry cohort. The multiple sclerosis walking scale msws 12 was developed to measure the impact of multiple sclerosis on walking. The msws12v1 was completed at screening and all scheduled and unscheduled study visits. The 12item multiple sclerosis walking scale msws12 is a selfreport measure of the impact of ms on the individuals walking ability. 10 an example of the baseline record form and baseline questionnaire booklet can be found at. Author links open overlay panel marina gonzalez del rio a miguel merchan ruiz a b. Selecting rehabilitation outcome measures for people with multiple. Mapping the 12item multiple sclerosis walking scale to.
Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. The most recent and best validated of these is the 12item multiple sclerosis walking scale msws12. Validation of patient determined disease steps pdds. Gait impairment is reported by 85% of patients with multiple sclerosis ms as main complaint.
The higher the scorepercentage, the greater the perceived impact ms is having on walking ability. May 01, 2014 for example, the 12 item multiple sclerosis walking scale, berg balance scale, multiple sclerosis impact scale, and visual analog scale for fatigue all received ratings of 3 or 4 for the great majority of settings and edss levels, indicating their appropriateness for tracking patient status over a longterm period or as a patient transitions. The aim of this study was to crossculturally adapt and validate the msws12 for the italian population with ms. Mos pain effects scale pes multiple sclerosis functional composite msfc multiple sclerosis quality of life54 msqol54 multiple sclerosis quality of life inventory msqli paced auditory serial addition test pasat. The most recent and best validated of these is the 12 item multiple sclerosis walking scale msws 12. Preliminary psychometric evaluation data quality, scaling assumptions, acceptability, reliability, validity was undertaken in the data generated by 602 people.
Jun 24, 2016 the multiple sclerosis walking scale msws 12 is the predominant patientreported measure of multiple sclerosis ms elated walking ability, yet it had not been analyzed using item response theory irt, the emerging standard for patientreported outcome pro validation. The 12item multiple sclerosis walking scale msws 12 what does this author special investigating alternative medicine but in many cases most patients to ever be truly better improving the patient has been brought on by facial movements through even with associated with multiple sclerosis before contract. Ecological validity is suggested since abc discriminated between users of assistive walking device and nonusers. At a glance prediction of oxygen uptake during walking in. Full text mapping of multiple sclerosis walking scale. Here we report the results of the multiple sclerosis and extract of cannabis musec study that aimed to substantiate the patient based findings of previous studies. Possible secondary outcomes for the definitive trial. Selecting rehabilitation outcome measures for persons. The aim of this study is to examine the psychometric properties of the walk12g in people with multiple sclerosis ms and parkinsons disease pd. Crosssectional msws12 to eq5d cross walking analysis.
Walking function was assessed by the timed 25foot walk test t25fwt, the 6minute walk test 6mwt, and the 12item multiple sclerosis walking scale msws12. Pdf italian validation of the 12item multiple sclerosis. Hobart jc, riazi a, lamping dl, fitzpatrick r, thompson aj. Diego cadavid, neurologist in cambridge, ma us news. Measuring the impact of ms on walking ability neurology. Ms multiple sclerosis mri magnetic resonance imaging msfc multiple sclerosis functional composite msis29 multiple sclerosis impact scale msws12 12item multiple sclerosis walking scale ncd national coverage determination nice national institute for health and care excellence nnt number needed to treat nr not reported or odds ratio.
Existing measures of functional status were inadequate, clinicianreported, focused on walking, and burdensome to complete. In doubleblind phase iii studies fampridine, compared with placebo, improved walking ability in adults with multiple sclerosis and walking impairment. An exemplar using the 12item multiple sclerosis walking scale. To map the 12 item multiple sclerosis walking scale msws 12 onto the euroqol 5dimension eq5d healthutility index in multiple sclerosis ms patients participating in the north american research committee on multiple sclerosis narcoms registry. The 12item ms walking scale msws12 assesses patients measurement of walking quality. The 12item multiple sclerosis walking scale msws12 is a new, selfrated measure of walking ability. Importance of women informing clinicians if they are or plan to become pregnant or plan to breastfeed. Ambulation index ai bladder control scale blcs bowel control scale bwcs disease steps ds. Other than for self reported ambulatory disability based on the 12 item multiple sclerosis walking scale msws 12 in the ampyra label, the lack of probased labeling claims suggests a gap in the availability of suitable pro measures for use in.
The msws12 is a patientrated measure of the impact of ms on walking that was developed using standard methods of test construction and validated in community and hospitalresiding samples of individuals with ms 2. The multiple sclerosis walking scale msws12 is the predominant patientreported measure of multiple sclerosis ms elated walking ability, yet it had not been analyzed using item response theory irt, the emerging standard. Physical therapists working with people with multiple sclerosis ms have additional. Development, refinement, and psychometric validation using an online community. Spearman rho correlations were used to evaluate relationships between spasticity measures, measures of walking speed and endurance, and selfperceived limitations in walking. Homebased physical telerehabilitation in patients with. An equation for mapping the msws12 to the eq5d was previously developed and validated using a north american research committee on ms narcoms registry cohort. To date, there is limited evidence regarding the validity of pdds scores, despite its sound conceptual development and broad inclusion in ms research. The multiple sclerosis walking scale msws12 assesses the impact of ms on walking ability from the patients perspective, but in its current form, is not amenable for use in many policy decision making settings. Italian validation of the 12item multiple sclerosis. Function, disability, and handicap,12 aiming to select. Six ms outpatient clinics across italy enrolled subjects. A conversation with your doctor about walking difficulty might be an important first step. A recent study confirmed the association between msws12 scores and t25fw and 6mw performance and showed the association between msws12 scores and spatial and temporal parameters of gait 8.
The 12item multiple sclerosis walking scale msws 12 is a patientreported outcome that assesses the impact of walking impairment in people with ms. Objective multiple sclerosis ms is associated with chronic symptoms, including muscle stiffness, spasms, pain and insomnia. The patients were guided by the home telecare units. In the ampyra clinical trials, it was used to demonstrate the clinical meaningfulness of change in walking speed. The original scoring provides options 15 for each item, with 1 meaning no limitation and 5 meaning extreme limitation on the gaitrelated item. To map the 12item multiple sclerosis walking scale msws12 onto the euroqol 5dimension eq5d healthutility index in multiple sclerosis ms patients participating in the north american research committee on multiple sclerosis narcoms registry. Multiple sclerosis the 12item multiple sclerosis walking scale msws 12 involves the damage to your email box. The 12item multiple sclerosis walking scale msws12 is a selfreport measure of the impact of. Other than for self reported ambulatory disability based on the 12 item multiple sclerosis walking scale msws12 in the ampyra label, the lack of pro based labeling claims regarding improvements in ms symptoms or functional impacts suggests a gap in that availability of suitable pro instruments for use in assessing treatment benefit in. Twelve item ms walking scale msws12 sailing sclerosis. Feb 03, 2016 the 12 item multiple sclerosis walking scale msws 12 is a patientreported outcome that assesses the impact of walking impairment in people with ms.
Sara strzok, sophie cleanthous, farrah pompilus, stefan j cano, patrick marquis, stanley cohan, myla d goldman, kiren kresareahl, jennifer petrillo and carmen castrilloviguera. Mapping the 12item multiple sclerosis walking scale to the. Many other disabling neurological conditions affect patients ability to walk, and a generic measure of walking could provide valuable insights into patients perceptions in clinical trials and epidemiological studies as well as routine clinical. The multiple sclerosis walking scale12 msws12 is a valid patientreported questionnaire rating walking ability in pwms. Identification and validation of clinically meaningful. The multiple sclerosis rating scale, revised msrsr. Six ms outpatient clinics across italy enrolled subjects between june 20 and. The first 12 questions of this guide are based on the 12item multiple sclerosis walking scale msws12a validated, selfreported patient questionnaire rating the effect of ms on walking. Sep 29, 2011 the walk12g was adapted from the 12item multiple sclerosis walking scale as a generic patientreported rating scale for walking difficulties in everyday life. Other than for self reported ambulatory disability based on the 12 item multiple sclerosis walking scale msws 12 in the ampyra label, the lack of probased labeling claims suggests a gap in the availability of suitable pro measures for use in assessing treatment benefit in ms trials. Mapping the 12item multiple sclerosis walking scale to the euroqol 5dimension index measure in north american multiple sclerosis patients. Identifying an important change threshold for the multiple. The 12item multiple sclerosis walking scale msws12 is a patientreported outcome measure that assesses patients perception of the impact of multiple sclerosis ms on walking ability, but cannot be used in costeffectiveness or costutility analyses which require a healthutility score to calculate qualityadjusted lifeyears.
Walking assessments had high reliability and were correlated with related measures, including the 12item multiple sclerosis walking scale msws12. Objective to map the 12item multiple sclerosis walking scale msws12 onto. Evaluating change in mobility in people with multiple sclerosis. Identification and validation of clinically meaningful benchmarks in the 12item multiple sclerosis walking scale myla d goldman, melanie d ward, robert w motl, david e jones, john h pula, and diego cadavid. Mapping from the multiple sclerosis walking scale msws12. Outcome measures for individuals with multiple sclerosis. Multiple sclerosis impact scale msis29 brain oxford. Validity and reliability of four clinical gait measures in. Assessment of clinically meaningful improvements in self. Gait impairment is commonly in people with multiple sclerosis ms. Pdf testing patientreported outcome measurement equivalence. Pdf mapping the 12item multiple sclerosis walking scale. One hundred fortynine patients in the community and 53 hospital outpatients with ms completed the msws12 and other outcome measures. As validation of scores from a measure is an ongoing and evolving process, the provision of additional evidence is warranted that confirms and extends the validity of inferences from scores on the msws 12.
The walk12g was adapted from the 12item multiple sclerosis walking scale as. Twelve item ms walking scale msws 12 graph patient progress over time twelve item ms walking scale use the graphs below to plot the percentage score from the questionnaire at each visit. Testing patientreported outcome measurement equivalence in multinational clinical trials. The 12item multiple sclerosis walking scale msws12. Self reported walking ability was measured using the multiple sclerosis walking scale 12 msws 12. This study aimed to profile gait pathology in gaitimpaired patients with ms using comprehensive 3d gait analysis and. Assessing walking disability in multiple sclerosis. Multiple sclerosis, outcomes, responsiveness, mobility, study design, measures of. This study developed an equation for predicting the energy expenditure during walking in persons with multiple sclerosis ms. Many other disabling neurological conditions affect patients ability to walk, and a generic measure of walking could provide valuable insights into patients perceptions in clinical trials and epidemiological studies as well as routine clinical practice. Ms multiple sclerosis msis29 multiple sclerosis impact scale msfc multiple sclerosis functional composite msws12 12item multiple sclerosis walking scale neda no evidence of disease activity nice national institute for health and care excellence pasat progression of paced auditory serial addition test. Multiple sclerosis walking scale12 and oxygen cost of.
Profiling walking dysfunction in multiple sclerosis. Multiple sclerosis outcome measures taskforce apta. Italian validation of the 12item multiple sclerosis walking. The multiple sclerosis walking scale 12 msws 12 is a 12 item patientrated measure of the impact of ms on walking.
May 18, 20 the 12item multiple sclerosis walking scale msws12 is a patientreported outcome measure that assesses patients perception of the impact of multiple sclerosis ms on walking ability, but cannot be used in costeffectiveness or costutility analyses which require a healthutility score to calculate qualityadjusted lifeyears. It consists of 12 questions concerning the limitations to walking due to ms during the past 2 weeks. Walking impairment has a major influence on the qualityoflife of people with multiple sclerosis ms. Siponimod for the treatment of secondary progressive. Each patient received a customtailored rehabilitative exercise program prescribed by a physical therapist during a clinic visit. Findings from the multinational enhance study in walking disabled participants with multiple sclerosis expanded disability status scale edss score 4. Predictors were walking speed and the 12item multiple sclerosis walking scalean index of walking problems. The participants completed a demographic questionnaire, including a history of falls, and. This study examined the validity of the pdds based on 1 the association with expanded disability status scale.
A randomized crossover trial of dalfampridine extended. Crosscultural adaptation and validation of the 12item. Mapping the 12item multiple sclerosis walking scale to the euroqol. Abstract multiple sclerosis ms is a complex chronic, progressing disease that contributes to poor quality of life qol for patients and. A change will be indicated by a reduction or increase.
Walking function was assessed by the timed 25foot walk test t25fwt, the 6minute walk test 6mwt, and the 12 item multiple sclerosis walking scale msws 12. Importance of informing patients of other important precautionary information. Multiple sclerosis outcome measures taskforce compendium of instructions for outcome measures 12. Jun 18, 2012 in developing the patientslikeme online platform for patients with multiple sclerosis ms, we required a patientreported assessment of functional status that was easy to complete and identified disability in domains other than walking. Multiple sclerosis impact scale msis29 the following questions ask for your views about the impact of ms on your daytoday life during the past two weeks for each statement, please circle the one number that best describes your situation please answer all questions in the past two weeks, how much has. Jul 27, 2017 walkingmultiple sclerosis walking scale12 item msws12 version 2. Transcript of interview on ampyra research, ms walking. The msws 12 is a patientrated measure of the impact of ms on walking that was developed using standard methods of test construction and validated in community and hospitalresiding samples of individuals with ms 2. Healthrelated quality of life euroqol eq5d5l and the 29item multiple sclerosis impact scale msis29 version 2. Bi barthel index, edss expanded disability status scale, eq5d euroqol, es effect size, fams functional assessment of multiple sclerosis, ghq 12 12 item version of the general health questionnaire, msis29 multiple sclerosis impact scale, nhnn national hospital for neurology and neurosurgery, sf36 medical outcomes study 36. Transcript of interview on ampyra research, ms walking ability and longterm use.
Research article italian validation of the 12item multiple. Sep 23, 2015 the 12item multiple sclerosis walking scale msws 12 is a patientreported outcome that assesses the impact of walking impairment in people with ms. The higher the scorepercentage, the greater the perceived impact ms is. Full text mapping of multiple sclerosis walking scale msws. Research article italian validation of the 12item multiple sclerosis. Multiple sclerosis walking scale 12 version 1 msws12v1 the msws12v1 is a 12 item questionnaire that asks subjects to rate, on a 5point scale from 1not at all to 5extremely, their msrelated mobility limitations during the preceding 2 weeks. The patient determined disease steps pdds is a promising patientreported outcome pro of disability in multiple sclerosis ms. Gait dysfunction is a common and relevant symptom in multiple sclerosis ms. The scale has not been independently validated for use in differing ms populations. The multiple sclerosis walking scale is a selfassessment scale which measures the impact of ms on walking. The multiple sclerosis walking scale msws12 was developed to measure the impact of multiple sclerosis on walking. Guidelines and best practices for appropriate use of.
We recruited 12 consecutive patients with a known diagnosis of ms. The abc discriminated between multiple fallers and nonfallers but not between men and women. Pdf mapping the 12item multiple sclerosis walking scale to. Confirmation and extension of the validity of the multiple. Walking impairment has o en been measured in clinical research and practice using the expanded disability status scale edss,thetimedfootwalktfw, theminute walk mw, and quantitative analysis gait kinematics. Multiple sclerosis outcome measures taskforce compendium of. Confirming the validity and responsiveness of the multiple.
Mapping of multiple sclerosis walking scale msws12 to five. Abstract dynamometerbased measure of spasticity confirms. Use the graphs below to plot the percentage score from the questionnaire at each visit. Multiple sclerosis ms is a chronic autoimmunemediated disorder that affects approximately 1 million people in the united states. For the improvement of walking in adult patients with multiple sclerosis with walking disability edss expanded disability status scale 47. This was shown using the 12item multiple sclerosis walking scale msws12, a validated, selfreported patient questionnaire rating the effect of ms on walking. Most patients with multiple sclerosis ms eventually experience walking disability. A change will be indicated by a reduction or increase in the score over time. Crosssectional msws 12 to eq5d cross walking analysis. Patients and methods patients with stable ms at 22 uk centres were randomised to oral cannabis extract. Psychometric performance of a generic walking scale walk12g. This study was conducted based on the recommendations published from the consensus conference on outcome measures in gait and fatigue sponsored by the consortium of multiple sclerosis centers cmsc in november. The 12item multiple sclerosis walking scale msws12 provides a patientreported outcome of the impact of ms on walking.
976 1309 1029 1457 643 571 337 1400 1090 979 280 1223 1059 389 1138 1506 385 1177 1236 1031 1532 417 874 701 231 173 905 236 409 979 1079 1560 439 715 1399 1351 977 946 1293 1364 1212